These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)]. Baldoli E, Sardi A, Caravaggi AM, Bianchi G. Boll Chim Farm; 1972 Aug; 111(8):480-8. PubMed ID: 4647088 [No Abstract] [Full Text] [Related]
5. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative. Bellasio E, Campi A. Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255 [Abstract] [Full Text] [Related]
17. Effects of 3-[N-(2-chlorobenzyl)amino]-6-(1H-imidazol-1-yl) pyridazine dihydrochloride on various aromatase enzyme systems and experimental breast cancer. Bandoh K, Ishizuka Y, Sato M. Arzneimittelforschung; 1995 Aug; 45(8):897-900. PubMed ID: 7575757 [Abstract] [Full Text] [Related]
18. Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150. Maseri A, Pesola A, L'Abbate A, Contini C, Magini G. J Int Med Res; 1976 Aug; 4(6):402-9. PubMed ID: 1027634 [Abstract] [Full Text] [Related]